Targeting PD-1/PD-L1 and CTLA-4 Immune Checkpoints for Therapeutic Advancement in Hepatocellular Carcinoma.

Sharma KK, Barti H, Tyagi SJ, Mohsin M, Kumar G

Open source

DOI
10.2174/0115665232419361251203152638
Published
2026 Jul 31
Container
Current gene therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115665232419361251203152638,
  title = {Targeting PD-1/PD-L1 and CTLA-4 Immune Checkpoints for Therapeutic Advancement in Hepatocellular Carcinoma.},
  author = {Sharma KK and Barti H and Tyagi SJ and Mohsin M and Kumar G},
  year = {2026},
  journal = {Current gene therapy},
  doi = {10.2174/0115665232419361251203152638},
  url = {https://doi.org/10.2174/0115665232419361251203152638}
}

RIS

TY  - JOUR
TI  - Targeting PD-1/PD-L1 and CTLA-4 Immune Checkpoints for Therapeutic Advancement in Hepatocellular Carcinoma.
AU  - Sharma KK
AU  - Barti H
AU  - Tyagi SJ
AU  - Mohsin M
AU  - Kumar G
PY  - 2026
JO  - Current gene therapy
DO  - 10.2174/0115665232419361251203152638
UR  - https://doi.org/10.2174/0115665232419361251203152638
ER  - 

APA

KK, S., H, B., SJ, T., M, M., & G, K. (2026). Targeting PD-1/PD-L1 and CTLA-4 Immune Checkpoints for Therapeutic Advancement in Hepatocellular Carcinoma.. Current gene therapy. https://doi.org/10.2174/0115665232419361251203152638

Source records